Abstract
Primary splenic lymphomas are rare with the majority of lymphomas in spleen being secondary to an extra-splenic lymphoma. We aimed to analyze the epidemiological profile of the splenic lymphoma and review the literature. This was a retrospective study including all splenectomies and splenic biopsies from 2015 to September 2021. All the cases were retrieved from Department of Pathology. Detailed histopathological, clinical and demographic evaluation was done. All the lymphomas were classified according to WHO 2016 classification. A total of 714 splenectomies were performed for a variety of benign causes, as part of tumor resections and for the diagnosis of lymphoma. Few core biopsies were also included. A total of 33 lymphomas diagnosed in the spleen, primary splenic lymphomas constituted 84.84% (n = 28) of the cohort with 5 (15.15%) having the primary site elsewhere. The primary splenic lymphomas constituted 0.28% of all the lymphomas arising at various sites. Adult population (19–65 years) formed the bulk (78.78%) with a slight male preponderance. Splenic marginal zone lymphomas (n = 15, 45.45%) comprised of major proportion of cases followed by primary splenic diffuse large B-cell lymphoma (n = 4, 12.12%). Splenectomy was the main course of treatment for SMZL with a good overall outcome, with chemotherapy ± radiotherapy forming the mainstay in other lymphomas. Lymphomas in spleen can be infiltrative or a primary, hence proper clinic-radiological and pathological evaluation is required. Appropriate management is guided by the precise and detailed evaluation by the pathologist, requiring understanding of the same.
Similar content being viewed by others
Data Availability
Most of the raw data submitted as tables. For any further clarification the data will be available. The data was presented in SOHO Italy 2020. The abstract published Jain, S., Mallick, S., Ramteke, P., Gogia, A., Agarwal, M., Dass, J., Yadav, R., & Sharma, M. (2020). Pandora box of Lymphomas in Spleen: Session: Non Hodgkin and Hodgkin Lymphomas. Hematology Reports, 12(s1).
References
Gobbi PG, Grignani GE, Pozzetti U et al (1994) Primary splenic lymphoma: does it exist? Haematologica 79(3):286–293
Iannitto E, Tripodo C (2011) How I diagnose and treat splenic lymphomas. Blood 117(9):2585–2595. https://doi.org/10.1182/blood-2010-09-271437
Ingle SB, Hinge Ingle CR (2016) Primary splenic lymphoma: Current diagnostic trends. World J Clin Cases 4(12):385–389. https://doi.org/10.12998/wjcc.v4.i12.385
Dasgupta T, Coombes B, Brasfield RD (1965) Primary malignant neoplasms of the spleen. Surg Gynecol Obstet 120:947–960
Jain S, Lone MR, Goswami A et al (2021) Lymphoma subtypes in India: a tertiary care center review. Clin Exp Med 21(2):315–321. https://doi.org/10.1007/s10238-021-00683-2
Skarin AT, Davey FR, Moloney WC (1971) Lymphosarcoma of the spleen. Results of diagnostic splenectomy in 11 patients. Arch Intern Med 127(2):259–265
Kehoe J, Straus DJ (1988) Primary lymphoma of the spleen. Clinical features and outcome after splenectomy. Cancer. 62(7): 1433–1438. https://doi.org/10.1002/1097-0142(19881001)62:7<1433::aid-cncr2820620731>3.0.co;2-v
Ahmann DL, Kiely JM, Harrison EG, Payne WS (1966) Malignant lymphoma of the spleen. A review of 49 cases in which the diagnosis was made at splenectomy. Cancer. 19(4): 461–469. https://doi.org/10.1002/1097-0142(196604)19:4<461::aid-cncr2820190402>3.0.co;2-x
Dachman AH, Buck JL, Krishnan J, Aguilera NS, Buetow PC (1998) Primary non-Hodgkin’s splenic lymphoma. Clin Radiol 53(2):137–142. https://doi.org/10.1016/s0009-9260(98)80061-5
Kraemer BB, Osborne BM, Butler JJ (1984). Primary splenic presentation of malignant lymphoma and related disorders. A study of 49 cases. Cancer. 54(8): 1606–1619. https://doi.org/10.1002/1097-0142(19841015)54:8<1606::aid-cncr2820540823>3.0.co;2-5
Li M, Zhang L, Wu N, Huang W, Lv N (2013) Imaging findings of primary splenic lymphoma: a review of 17 cases in which diagnosis was made at splenectomy. PLoS ONE 8(11):e80264. https://doi.org/10.1371/journal.pone.0080264
Gujral S, Lad P, Subramanian P et al (2011) Histopathological audit of splenectomies received at a cancer hospital. Indian J Pathol Microbiol 54(3):487. https://doi.org/10.4103/0377-4929.85080
Papadaki T, Stamatopoulos K, Belessi C et al (2007) Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases. Am J Surg Pathol 31(3):438–446. https://doi.org/10.1097/01.pas.0000213419.08009.b0
Merli M, Carli G, Arcaini L, Visco C (2016) Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma. World J Gastroenterol 22(38):8447. https://doi.org/10.3748/wjg.v22.i38.8447
Santos TSD, Tavares RS, de Farias DLC (2017) Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges. Rev Bras Hematol E Hemoter 39(2):146–154. https://doi.org/10.1016/j.bjhh.2016.09.014
Ruiz-Ballesteros E, Mollejo M, Rodriguez A et al (2005) Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 106(5):1831–1838. https://doi.org/10.1182/blood-2004-10-3898
Shimono J, Miyoshi H, Kiyasu J et al (2017) Clinicopathological analysis of primary splenic diffuse large B-cell lymphoma. Br J Haematol 178(5):719–727. https://doi.org/10.1111/bjh.14736
Grosskreutz C, Troy K, Cuttner J (2002) Primary splenic lymphoma: report of 10 cases using the REAL classification. Cancer Invest 20(5–6):749–753. https://doi.org/10.1081/CNV-120002492
Takeshita M, Sakai H, Okamura S et al (2005) Splenic large B-cell lymphoma in patients with hepatitis C virus infection. Hum Pathol 36(8):878–885. https://doi.org/10.1016/j.humpath.2005.06.005
Li S, Mann KP, Holden JT (2004) T-cell-rich B-cell lymphoma presenting in the spleen: a clinicopathologic analysis of 3 cases. Int J Surg Pathol 12(1):31–37. https://doi.org/10.1177/106689690401200105
Bairey O, Zimra Y, Rabizadeh E, Shaklai M (2004) Expression of adhesion molecules on leukemic B cells from chronic lymphocytic leukemia patients with predominantly splenic manifestations. Isr Med Assoc J IMAJ 6(3):147–151
Hermann RE, De Haven KE, Hawk WA (1968) Splenectomy for the diagnosis fo splenomegaly. Ann Surg 168(5):896–900. https://doi.org/10.1097/00000658-196811000-00017
Kansal R, Ross CW, Singleton TP, Finn WG, Schnitzer B (2003) Histopathologic features of splenic small B-cell lymphomas. A study of 42 cases with a definitive diagnosis by the World Health Organization classification. Am J Clin Pathol 20(3):335–347. https://doi.org/10.1309/HWG0-84N3-F3LR-J8XB
Chan JKC (2003) Splenic involvement by peripheral T-cell and NK-cell neoplasms. Semin Diagn Pathol 20(2):105–120. https://doi.org/10.1016/S0740-2570(03)00013-3
Vig T, Kodiatte TA, Manipadam MT, Aboobacker FN (2018) A rare case of splenic diffuse red pulp small B-cell lymphoma (SDRPL): a review of the literature on primary splenic lymphoma with hairy cells. Blood Res 53(1):74–78. https://doi.org/10.5045/br.2018.53.1.74
Kanellis G, Mollejo M, Montes-Moreno S et al (2010) Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica 95(7):1122–1129. https://doi.org/10.3324/haematol.2009.013714
Curiel-Olmo S, Mondéjar R, Almaraz C et al (2017) Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood 129(8):1042–1045. https://doi.org/10.1182/blood-2016-11-751024
Martinez D, Navarro A, Martinez-Trillos A et al (2016) NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease. Am J Surg Pathol 40(2):192–201. https://doi.org/10.1097/PAS.0000000000000523
Pilon VA, Davey FR, Gordon GB, Jones DB (1982) Splenic alterations in hairy-cell leukemia: II an electron microscopic study. Cancer. 49(8): 1617–1623. https://doi.org/10.1002/1097-0142(19820415)49:8<1617::aid-cncr2820490815>3.0.co;2-c
Ocio EM, Hernández JM, Mateo G et al (2005) Immunophenotypic and Cytogenetic Comparison of Waldenström’s Macroglobulinemia with Splenic Marginal Zone Lymphoma. Clin Lymphoma 5(4):241–245. https://doi.org/10.3816/CLM.2005.n.007
Pro B, Allen P, Behdad A (2020) Hepatosplenic T-cell lymphoma: a rare but challenging entity. Blood 136(18):2018–2026. https://doi.org/10.1182/blood.2019004118
Osuji N, Matutes E, Catovsky D, Lampert I, Wotherspoon A (2005) Histopathology of the spleen in T-cell large granular lymphocyte leukemia and t-cell prolymphocytic leukemia: a comparative review. Am J Surg Pathol 29(7):935–941. https://doi.org/10.1097/01.pas.0000160732.43909.3f
Cao Q, Huang Y, Ye Z, Liu N, Li S, Peng T (2014) Primary spleen extranodal NK/T cell lymphoma, nasal type, with bone marrow involvement and CD30 positive expression: a case report and literature review. Diagn Pathol 9:169. https://doi.org/10.1186/s13000-014-0169-9
Farrer-Brown G, Bennett MH, Harrison CV, Millett Y, Jelliffe AM (1972) The diagnosis of Hodgkin’s disease in surgically excised spleens. J Clin Pathol 25(4):294–300. https://doi.org/10.1136/jcp.25.4.294
Bairey O, Shvidel L, Perry C et al (2015) Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survival: primary Splenic DLBCL. Cancer 121(17):2909–2916. https://doi.org/10.1002/cncr.29487
Funding
The data was collected as part of projects- SERB ECR/2015/415, SERB EEQ/2016/402.
Author information
Authors and Affiliations
Contributions
Concept: SM, Data Collection: SJ, PR, TM. Manuscript writing: SJ, PR Clinical Information: AG, MA, MM, RP, SB. AS. Manuscript review: SM, JD, MCS. Final Review–SM.
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest amongst the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jain, S., Ramteke, P., Gogia, A. et al. Splenic Lymphomas: A Tertiary Care Center Experience and Review of Literature. Indian J Hematol Blood Transfus 39, 402–412 (2023). https://doi.org/10.1007/s12288-022-01621-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-022-01621-2